# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 123

Extent: E+W+S+N.I.

Before regulation 156 insert—
“Amendment of regulation 196 (urgent action)
156ZA In regulation 196—
(a) in the italic heading immediately preceding it, after “Urgent action” insert “ and major safety review ”;
(b) in paragraph (1), for “The licensing authority must initiate the Section 4 procedure by informing” substitute “ In the case of a medicinal product authorised for sale or supply under a UKMA(NI), UKMA(UK), THR(NI), THR(UK) or Article 126a authorisation, the licensing authority must inform ”;
(c) omit sub-paragraph (2B);
(d) omit paragraphs (4) to (7);
(e) in paragraph (8), omit the definition of “EU urgent action procedure” and “Section 4 procedure”.”.

---
Source: https://www.legislation.gov.uk/uksi/2020/1488/schedule/2/paragraph/123 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-123
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.